Literature DB >> 1137149

Gas-liquid chromatographic electron capture determination of some monosubstituted guanido-containing drugs.

P Erdtmansky, T J Goehl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1137149     DOI： 10.1021/ac60354a049

Source DB:  PubMed          Journal:  Anal Chem        ISSN： 0003-2700            Impact factor:   6.986


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and chronic toxicity of cyclosporine A in genetic hydroxylation-deficient dark Agouti rats.

Authors:  S Koehn; F J Frey; R F Speck; T Zeugin; T Schaffner; A Zimmermann; B M Frey
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  Polymorphism of carbon oxidation of drugs and clinical implications.

Authors:  T P Sloan; A Mahgoub; R Lancaster; J R Idle; R L Smith
Journal:  Br Med J       Date:  1978-09-02

3.  Genetically determined oxidation capacity and the disposition of debrisoquine.

Authors:  T P Sloan; R Lancaster; R R Shah; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

4.  3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.

Authors:  Yueying Zhen; Ondrej Slanar; Kristopher W Krausz; Chi Chen; Josef Slavík; Kerry L McPhail; T Mark Zabriskie; Frantisek Perlík; Frank J Gonzalez; Jeffrey R Idle
Journal:  Drug Metab Dispos       Date:  2006-06-16       Impact factor: 3.922

5.  Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama.

Authors:  L F Jorge; T D Arias; T Inaba; P R Jackson
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

6.  The metabolism of [14C]-debrisoquine in man.

Authors:  J R Idle; A Mahgoub; M M Angelo; L G Dring; R Lancaster; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

7.  Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype?

Authors:  M Pirovino; U Honegger; O Müller; T Zysset; A Küpfer; M Tinel; D Pessayre
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

8.  Simultaneous assay of isotopic enrichment and concentration of guanidinoacetate and creatine by gas chromatography-mass spectrometry.

Authors:  Takhar Kasumov; Lourdes L Gruca; Srinivasan Dasarathy; Satish C Kalhan
Journal:  Anal Biochem       Date:  2009-07-29       Impact factor: 3.365

Review 9.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.